Peter Heerma
EVP, CHIEF COMMERCIAL OFFICER at Travere Therapeutics. Based in San Diego, California.
- Rank
- 13392nd of 14,644
- Companies held
- 1
- Largest holding
- TVTX, 100.0% of total
- Latest SEC filing
- Sep 17, 2026
What the $5.6M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Travere Therapeutics TVTX Common Stock | Directly | 117,066 | $47.84 | $5.6M | 100.0% | Form 4, Sep 17, 2026 |
Share counts are the amounts Peter Heerma reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | Sold | TVTX | 8,282 | $65.07 | $539K | View |
| Sep 16, 2026 | Sold | TVTX | 93,604 | $63.25 | $5.9M | View |
| Sep 16, 2026 | Sold | TVTX | 79,113 | $63.65 | $5.0M | View |
| Sep 15, 2026 | Sold | TVTX | 1,431 | $65.31 | $93K | View |
| Sep 15, 2026 | Sold | TVTX | 1,400 | $63.65 | $89K | View |
| Sep 15, 2026 | Sold | TVTX | 27,421 | $62.59 | $1.7M | View |
| Sep 15, 2026 | Sold | TVTX | 71,938 | $62.05 | $4.5M | View |
| May 5, 2026 | Sold | TVTX | 2,174 | $46.65 | $101K | View |
| Apr 14, 2026 | Sold | TVTX | 7,215 | $41.93 | $303K | View |
| Feb 3, 2026 | Sold | TVTX | 7,310 | $32.12 | $235K | View |
| Dec 24, 2025 | Sold | TVTX | 4,980 | $40.00 | $199K | View |
| Oct 31, 2025 | Sold | TVTX | 5,591 | $35.00 | $196K | View |
| Oct 28, 2025 | Sold | TVTX | 2,662 | $30.00 | $80K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 13389 | Patrick H. Mooney Chief Executive Officer, SpyGlass Pharma. Aliso Viejo, CA | $5.6M |
| 13390 | Matthew Jay Peterson Executive Vice President, UHS, Universal Health Services. King Of Prussia, PA | $5.6M |
| 13391 | Sigmund L. Cornelius Director, Phillips 66. Houston, TX | $5.6M |
| 13392 | Peter Heerma EVP, CHIEF COMMERCIAL OFFICER, Travere Therapeutics. San Diego, CA | $5.6M |
| 13393 | Terry L. Savage Director, CME Group. Chicago, IL | $5.6M |
| 13394 | Richard S. May Director, Trulieve Cannabis. Tallahassee, FL | $5.6M |
| 13395 | Brenda J. Bacon Director, FTI Consulting. Orlando, FL | $5.6M |
Other Travere Therapeutics insiders
All TVTX insiders- Eric M. Dube$20.7MCHIEF EXECUTIVE OFFICER. #5063 overall
- Steve Aselage$7.0MDirector. #10796 overall
- Elizabeth E. Reed$5.0MChief Legal Officer and GC. #14369 overall
- Jula Inrig$4.8MEVP, Head of R&D & CMO. #14614 overall
- Jeffrey A. Meckler$4.4MDirector. #14251 overall
- Gary A. Lyons$2.9MDirector. #4743 overall
Questions
How much stock does Peter Heerma own?
Peter Heerma holds $5,600,437 in listed stock based on SEC filings and current prices, mostly Travere Therapeutics (TVTX). That ranks 13392nd on the Stock Rich List.
Is this Peter Heerma's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Peter Heerma last buy or sell stock?
The most recent open-market trade on file is a sale of 8,282 TVTX shares on Sep 17, 2026 at $65.07.